No Data
No Data
jacobson pharma: Po Chai Herbal and PCHT entered into a purchase agreement with ulferts pharmaceuticals
jacobson pharma (02633) and jbm healthcare (02161) jointly announced that on November 11, 2024, Po Chai Herbal and PCHT (as sellers) entered into a sale and purchase agreement with ulferts pharmaceutical (as buyer). Po Chai Herbal and PCHT conditionally agreed to sell 0.0565 million shares and 0.044 million shares respectively, while ulferts pharmaceutical conditionally agreed to acquire the relevant sale shares, for a total consideration of 46.23 million Hong Kong dollars (i.e. 460 Hong Kong dollars per share). As of the date of this joint announcement, Po Chai
November 11th [Today's Investment Strategy]
[FISCO Selected Stocks] [Material Stock] Mitsui Metal <5706> 4827 yen (11/8) Engaged in functional materials, electronic materials, nonferrous metal refining, resource development, precious metal recycling, etc. The performance forecast for the fiscal year ending March 2025 has been revised upward. Operating profit is expected to be 56 billion yen (an increase of 76.7% compared to the previous period). It has been raised by about 19% from the previous forecast. In the first half, the sales volume of major products in the functional materials division increased, and there was an improvement in inventory factors associated with the volatility of nonferrous metal prices due to the trend of a weak yen.
Three key points to watch in the morning session - Lingering caution towards Trump trade continuation and tariffs.
In the morning session on the 11th, the following three points are worth noting: ■ Concerns about Trump Trade continuation and smoldering caution about tariffs ■ SoftBank, 25/3 upward revision operating profit 950 billion yen ← 900 billion yen ■ Focus points for the morning session: Proposal to ban continuous work for 14 days or more, Ministry of Health, Labour and Welfare consideration, possible review of maximum 48 days ■ Concerns about Trump Trade continuation and smoldering caution about tariffs Japanese stock market on the 11th started with selling pressure and is likely to develop into a market situation with a strong stalemate. On the 8th, the US market saw the Dow Jones Industrial Average
Concerns about tariffs persist despite the continuation of the Trump trade.
On the 11th, the Japanese stock market is likely to develop into a market with a strong sense of stalemate after starting with a selling trend. On the 8th, in the US market, the Dow Jones Industrial Average rose by 259 points, while the Nasdaq rose by 17 points. Buying due to policy expectations from the Trump administration continued. Following the Federal Open Market Committee (FOMC) meeting the previous day, Federal Reserve Chair Powell suggested the possibility of further interest rate cuts, and the Michigan Consumer Sentiment Index exceeded financial estimates, leading to a sense of reassurance. Chicago day
Keep an eye on Mitsui Gold and Keihan HD, while SUMCO and Hamamatsu Photonics are sluggish.
On the US stock market last weekend on the 8th, the dow jones industrial average rose by 259.65 points to 43,988.99, the nasdaq composite index rose by 17.32 points to 19,286.78, and the Chicago Nikkei 225 futures were down 365 yen from the Osaka day session to 39,135 yen. The exchange rate is 1 dollar = 152.60-70 yen. In today's Tokyo market, Ice Style <3660> saw its first quarter operating profit double compared to the same period last year, Kaken Pharmaceutical <4521> saw its first-half operating profit increase by 3.5 times compared to the same period last year, and the first-half operating profit increased by 26.
SoftBank, upward revision on 25/3, operating profit 950 billion yen ← 900 billion yen
SoftBank <9434> announced a revision to its financial estimates for the fiscal year ending in March 2025. The revenue has been upwardly revised from 6.2 trillion yen to 6.35 trillion yen, and the operating profit from 900 billion yen to 950 billion yen. The strong performance of its subsidiary, the leading smart phone payment provider PayPay, as well as the recovery of its mobile business, have contributed to this. [Positive evaluation] <9735> secom co midterm | <4521> Kaken Pharmaceutical midterm <7733> Olympus midterm | <8362> Fukui Bank revision <9005> Tokyu midterm | <4
No Data
No Data